Page last updated: 2024-10-21

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Intracranial Arteriosclerosis

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one has been researched along with Intracranial Arteriosclerosis in 1 studies

1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one: structure given in first source; inhibits guanylyl cyclase
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one : A member of the class of oxadiazoloquinoxalines that is 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline substituted at position 1 by an oxo group.

Intracranial Arteriosclerosis: Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Didion, SP1
Heistad, DD1
Faraci, FM1

Other Studies

1 other study available for 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Intracranial Arteriosclerosis

ArticleYear
Mechanisms that produce nitric oxide-mediated relaxation of cerebral arteries during atherosclerosis.
    Stroke, 2001, Volume: 32, Issue:3

    Topics: Animals; Basilar Artery; Cerebral Arteries; Cholesterol; Diet, Atherogenic; Dinoprost; Disease Model

2001